Article
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.
Nature communications - 12 Apr 2018
Gräf Stefan, Haimel Matthias, Bleda Marta, Hadinnapola Charaka, Southgate Laura, Li Wei, Hodgson Joshua, Liu Bin, Salmon Richard M, Southwood Mark, Machado Rajiv D, Martin Jennifer M, Treacy Carmen M, Yates Katherine, Daugherty Louise C, Shamardina Olga, Whitehorn Deborah, Holden Simon, Aldred Micheala, Bogaard Harm J, Church Colin, Coghlan Gerry, Condliffe Robin, Corris Paul A, Danesino Cesare, Eyries Mélanie, Gall Henning, Ghio Stefano, Ghofrani Hossein-Ardeschir, Gibbs J Simon R, Girerd Barbara, Houweling Arjan C, Howard Luke, Humbert Marc, Kiely David G, Kovacs Gabor, MacKenzie Ross Robert V, Moledina Shahin, Montani David, Newnham Michael, Olschewski Andrea, Olschewski Horst, Peacock Andrew J, Pepke-Zaba Joanna, Prokopenko Inga, Rhodes Christopher J, Scelsi Laura, Seeger Werner, Soubrier Florent, Stein Dan F, Suntharalingam Jay, Swietlik Emilia M, Toshner Mark R, van Heel David A, Vonk Noordegraaf Anton, Waisfisz Quinten, Wharton John, Wort Stephen J, Ouwehand Willem H, Soranzo Nicole, Lawrie Allan, Upton Paul D, Wilkins Martin R, Trembath Richard C, Morrell Nicholas W
Abstract excerpt
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis. Deleterious variation within components of the transforming growth factor-β pathway, particularly the bone morphogenetic protein type 2 receptor (BMPR2), underlies most heritable forms of PAH. To identify the missing heritability we perform whole-genome sequencing in 1038 PAH index cases and 6385 PAH-negative control subjects....
Read the complete abstract on PubMed